Published Reported
Marius Pharma Tests KYZATREX in Seniors, Targeting Untapped Market
Testosterone therapy was not associated with an increased risk of major adverse cardiovascular events, but pulmonary embolism and atrial fibrillation were more frequent in the treatment group.